Sichuan Kelun Biotech (6990)

Hong Kong
Currency in HKD
259.40
+2.20(+0.86%)
Closed
6990 Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Trading near 52-week High
Fair Value
Day's Range
252.40264.60
52 wk Range
120.20264.60
Sichuan Kelun Biotech is currently considered to be OvervaluedExplore our list of undervalued stocks for hidden opportunities
Key Statistics
Edit
Bid/Ask
258.40 / 259.40
Prev. Close
257.2
Open
257.2
Day's Range
252.4-264.6
52 wk Range
120.2-264.6
Volume
298.42K
Average Volume (3m)
358.56K
1-Year Change
74.85%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6990 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
228.50
Downside
-11.91%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week
Show more

Sichuan Kelun Biotech Company Profile

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs to address unmet medical needs in the People’s Republic of China and internationally. The company is developing various drugs to treat breast, non-small cell lung, and gastrointestinal cancer, as well as non-oncology diseases. Its product pipeline includes oncology drug candidates, such as SKB264 (sacituzumab tirumotecan), A166 (trastuzumab botidotin), SKB315, A167 (tagitanlimab), A140, and A400; and non-oncology drug candidates primarily to treat immune-mediated diseases, consisting of rheumatoid arthritis and alopecia areata comprising A223, A277, SKB378, and SKB336. The company has license and collaboration arrangements with Merck Sharp & Dohme LLC; Harbour BioMed Therapeutics Limited; and Ellipses Pharma Limited. The company was incorporated in 2016 and is headquartered in Chengdu, the People’s Republic of China. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. operates as a subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd.

Compare 6990 to Peers and Sector

Metrics to compare
6990
Peers
Sector
Relationship
P/E Ratio
−291.4x−5.7x−0.5x
PEG Ratio
−4.280.050.00
Price/Book
16.9x2.5x2.6x
Price / LTM Sales
29.0x11.1x3.0x
Upside (Analyst Target)
−11.1%14.4%53.8%
Fair Value Upside
Unlock13.2%9.6%Unlock

Analyst Ratings

18 Buy
0 Hold
1 Sell
Ratings:
19 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 228.50
(-11.91% Downside)

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

417.00
1211
+3.89%
11.94
0992
+0.67%
42.35
3888
+0.24%
88.80
VRT
+4.89%
28.50
2269
+1.97%

FAQ

What Is the Sichuan Kelun Biotech (6990) Stock Price Today?

The Sichuan Kelun Biotech stock price today is 259.40

What Stock Exchange Does Sichuan Kelun Biotech Trade On?

Sichuan Kelun Biotech is listed and trades on the Hong Kong stock exchange.

What Is the Stock Symbol for Sichuan Kelun Biotech?

The stock symbol for Sichuan Kelun Biotech is "6990."

What Is the Sichuan Kelun Biotech Market Cap?

As of today, Sichuan Kelun Biotech market cap is 58.45B.

What is Sichuan Kelun Biotech Earnings Per Share?

The Sichuan Kelun Biotech EPS is -0.858.

From a Technical Analysis Perspective, Is 6990 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.